Lanean...

Splicing variants of androgen receptor in prostate cancer

Significant advances in our understanding of continued androgen receptor (AR) signaling in castration-resistant prostate cancer have led to the development and FDA approval of two next-generation androgen-directed therapies, abiraterone and enzalutamide. These new therapies heralded a new era of pro...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Am J Clin Exp Urol
Egile Nagusiak: Zhang, Haitao, Zhan, Yang, Liu, Xichun, Qi, Yanfeng, Zhang, Guanyi, Sartor, Oliver, Dong, Yan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: e-Century Publishing Corporation 2013
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4219285/
https://ncbi.nlm.nih.gov/pubmed/25374896
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!